Collection of scientific works Nanosystems, nanomaterials, nanotechnologies Year 2023 Volume 21, Issue 3
English Ukrainian
Get the article →
vol year page
Issues PACS For subscribers For authors
Search →
Advanced Search

Issues

 / 

2023

 / 

vol. 21 / 

Issue 3

 


Download the full version of the article (in PDF format)

Ò. ². HALENOVA, N. G. RAKSHA, Ò. B. VOVK, K. ². BOGUTSKA, Î. Ì. SAVCHUK, and Yu. I. PRYLUTSKYY
The Effect of C60 Fullerenes on the Mechanokinetics of Skeletal Muscle Fatigue in Rats at the Administration of a Fraction of Peptides from the Blood Plasma of Patients with Cardioembolic Ischemic Stroke
665–673 (2023)

PACS numbers: 81.05.ub,82.39.Rt,83.80.Lz,87.19.Ff,87.19.R-,87.85.jc,87.85.Rs

The influence of a fraction of peptides (up to 5 kDa) obtained from the blood plasma of patients with cardioembolic ischemic stroke during the acute phase on the dynamics of skeletal muscle contraction in rats against the background of the antioxidant effect of C60 fullerenes is investigated. A complex potential therapeutic effect on the development of muscle fatigue is revealed; in particular, there are a significant reduction in the time of onset of muscle fatigue, an increase in its integrated power and the maximum possible level of force generation compared to the control that can contribute to the improvement of existing methods of treatment of muscle dysfunctions, as well as rehabilitation procedures.

Key words: skeletal muscle, muscle contraction dynamics, fatigue, C60 fullerene, blood-plasma peptide fraction of patients with cardioembolic ischemic stroke.

https://doi.org/10.15407/nnn.21.03.665

References
  1. V. L. Feigin, M. H. Forouzanfar, and R. Krishnamurthi et al., Lancet, 383, No. 9913: 245 (2014); doi:10.1016/s0140-6736(13)61953-4
  2. S. S. Virani, A. Alonso, and H. J. Aparicio et al., Circulation, 143, No. 8: e254 (2021); doi:10.1161/CIR.0000000000000950
  3. J. D³az Guzmàn, Neurologia, 1: 4 (2012); doi:10.1016/S0213-4853(12)70002-6
  4. J. M. Ferro, Lancet. Neurol., 2, No. 3: 177 (2003); doi:10.1016/s1474-4422(03)00324-7
  5. A. Arboix and J. Alioc, Curr. Cardiol. Rev., 6, No. 3: 150 (2010); doi:10.2174/157340310791658730
  6. W. Zhu, L. Churilov, B. C. V. Campbell, M. Lin, X. Liu, S. M. Davis, and B. Yanet, J. Stroke Cerebrovasc. Dis., 23, No. 10: 2888 (2014); doi:10.1016/j.jstrokecerebrovasdis.2014.07.018
  7. H. Kamel and J. S. Healey, Circ. Res., 120, No. 3: 514 (2017); doi:10.1161/CIRCRESAHA.116.308407
  8. C. D. Maida, R. L. Norrito, M. Daidone, A. Tuttolomondo, and A. Pinto, Int. J. Mol. Sci., 21, No. 18: 6454 (2020); doi:10.3390/ijms21186454
  9. T. Ivanics, Z. Mikl?s, Z. Ruttner, S. B?tkai, D. W. Slaaf, R. S. Reneman, A. T?th, and L. Ligeti, Pfl?gers Arch., 440, No. 2: 302 (2000); doi:10.1007/s004240051052
  10. H. Amani, R. Habibey, S. J. Hajmiresmail, S. Latifi, H. Pazoki-Toroudi, and O. Akhavan, J. Mater. Chem. B, 5, Iss. 48: 9452 (2017); https://doi.org/10.1039/C7TB01689A
  11. R. S. Foote, J. D. Pearlman, A. H. Siegel, and K. T. Yeo, J. Am. Coll. Cardiol., 44, No. 10: 1980 (2004); doi:10.1016/j.jacc.2004.08.045
  12. A. S. Maisel, P. Krishnaswamy, and R. M. Nowak et al., New Engl. J. Med., 347, No. 3: 161 (2002); doi:10.1056/NEJMoa020233
  13. L. L. Dugan, E. G. Lovett, K. L. Quick, J. Lotharius, T. T. Lin, and K. L. O’Malley, Parkinsonism Relat. Disord., 7, No. 3: 243 (2001); doi:10.1016/s1353-8020(00)00064-x
  14. S. V. Eswaran, Curr. Sci., 114: 1846 (2018); doi:10.18520/cs/v114/i09/1846-1850
  15. A. Grebinyk, S. Prylutska, S. Grebinyk, Yu. Prylutskyy, U. Ritter, O. Matyshevska, T. Dandekar, and M. Frohme, Nanoscale Res. Lett., 14, No. 13: 61 (2019); doi:10.1186/s11671-019-2894-1
  16. S. Y. Zay, K. I. Bogutska, D. N. Nozdrenko, and Y. I. Prylutskyy, Fiziol. Zh., 62, No. 3: 66 (2016) (in Ukrainian); https://doi.org/10.15407/fz62.03.066
  17. D. M. Nozdrenko, T. Yu. Matvienko, O. V. Vygovska, K. I. Bogutska, O. P. Motuziuk, N. Y. Nurishchenko, Yu. I. Prylutskyy, P. Scharff, and U. Ritter, Int. J. Mol. Sci., 22, Iss. 13: 6812 (2021); https://doi.org/10.3390/life12030332
  18. M. Kozyk, K. Strubchevska, T. Marynenko, A. Zlatska, T. Halenova, N. Raksha, O. Savchuk, T. Falalyeyeva, O. Kovalchuk, and L. Ostapchenko, Medicina, 59, Iss. 2: 238 (2023); https://doi.org/10.3390/medicina59020238
  19. D. N. Nozdrenko, S. M. Berehovyi, N. S. Nikitina, L. I. Stepanova, T. V. Beregova, and L. I. Ostapchenko, Biomed. Res., 29, Iss. 19: 3629 (2018); doi:10.4066/biomedicalresearch.29-18-1055
  20. D. N. Nozdrenko and K. I. Bogutska, Biopolym. Cell., 21, No. 3: 283 (2005); http://dx.doi.org/10.7124/bc.0006F3
  21. Yu. I. Prilutski, S. S. Durov, V. N. Yashchuk, T. Yu. Ogul’chansky, V. E. Pogorelov, Yu. A. Astashkin, E. V. Buzaneva, Yu. D. Kirghizov, G. V. Andrievsky, and P. Scharff, Europ. Phys. J. D, 9, Nos. 1–4: 341 (1999).
  22. Yu. I. Prylutskyy, V. M. Yashchuk, K. M. Kushnir, A. A. Golub, V. A. Kudrenko, S. V. Prylutska, I. I. Grynyuk, E. V. Buzaneva, P. Scharff, T. Braun, and O. P. Matyshevska, Mater. Sci. Engineer. C, 23, Nos. 1–2: 109 (2003).
  23. D. M. Nozdrenko, D. O. Zavodovsky, T. Yu. Matvienko, S. Yu. Zay, K. I. Bogutska, Yu. I. Prylutskyy, U. Ritter, and P. Scharff, Nanoscale Res. Lett., 12: 115 (2017); https://doi.org/10.1186/s11671-017-1876-4
  24. D. Ì. Nozdrenko, S. Yu. Zay, Î. P. Motuziuk, K. I. Bogutska, A. V. Ilchenko, and Yu. I. Prylutskyy, Nanosistemi, Nanomateriali, Nanotehnologii, 16, No. 3: 585 (2018) (in Ukrainian); https://doi.org/10.15407/nnn.16.03.585
  25. N. Gharbi, M. Pressac, M. Hadchouel, H. Szwarc, S. R. Wilson, and F. Moussa, Nano Lett., 5, No. 12: 2578 (2005); https://doi.org/10.1021/nl051866b
Creative Commons License
This article is licensed under the Creative Commons Attribution-NoDerivatives 4.0 International License
©2003—2023 NANOSISTEMI, NANOMATERIALI, NANOTEHNOLOGII G. V. Kurdyumov Institute for Metal Physics of the National Academy of Sciences of Ukraine.
E-mail: tatar@imp.kiev.ua Phones and address of the editorial office About the collection User agreement